drugset / Trial / NCT03887754

Therapeutic Issues for Autism

NCT03887754

Phase 2 Completed 80 enrolled Minia University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aimed to show the effects of hyperbaric oxygen therapy and/or Risperidone in improving symptoms of autism

Timeline

Start
2016-01
Primary completion
2018-01
Completion
2018-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Risperidone Other / unclassified 0.25 mg
Comparator Risperidone Other / unclassified 0.5 mg